Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Stoll

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Multiple Sclerosis and Related Disorders|February 24, 2023
A retrospective evaluation of seroconversion after COVID-19 during the early Omicron wave in fully vaccinated multiple sclerosis patients receiving anti-CD20 therapiesSharon Stoll, Shree Desai, Elle Levit
International Journal of MS Care|March 14, 2024
Validated, Quantitative, Machine Learning-Generated Neurologic Assessment of Multiple Sclerosis Using a Mobile ApplicationSharon Stoll, Charisse Litchman, Noah Rubin, et al.
Journal of Veterinary Medical Education|August 4, 2005
Veterinary students as elite performers: preliminary insightsDan Zenner, Gilbert A Burns, Kathleen L Ruby, et al.
Neurology and Therapy|January 5, 2024
Insights for Healthcare Providers on Shared Decision-Making in Multiple Sclerosis: A Narrative ReviewSharon Stoll, Kathleen Costello, Scott D Newsome, et al.
Multiple Sclerosis and Related Disorders|November 10, 2019
Validation of claims-based diagnoses of adult and pediatric neuromyelitis optica spectrum disorder and variations in diagnostic evaluation and treatment initiationSabrina Gmuca, Duriel I Hardy, Sona Narula, et al.
Frontiers in Neuroscience|October 2, 2023
Interim guidelines for the assessment and treatment of pain in children with multiple sclerosisCatherine Stratton, Areti Vassilopoulos, J Nicholas Brenton, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trialsStephen L Hauser, Gavin Giovannoni, Xavier Montalban, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Multiple Sclerosis and Related Disorders|February 24, 2023
A retrospective evaluation of seroconversion after COVID-19 during the early Omicron wave in fully vaccinated multiple sclerosis patients receiving anti-CD20 therapiesSharon Stoll, Shree Desai, Elle Levit
International Journal of MS Care|March 14, 2024
Validated, Quantitative, Machine Learning-Generated Neurologic Assessment of Multiple Sclerosis Using a Mobile ApplicationSharon Stoll, Charisse Litchman, Noah Rubin, et al.
Journal of Veterinary Medical Education|August 4, 2005
Veterinary students as elite performers: preliminary insightsDan Zenner, Gilbert A Burns, Kathleen L Ruby, et al.
Neurology and Therapy|January 5, 2024
Insights for Healthcare Providers on Shared Decision-Making in Multiple Sclerosis: A Narrative ReviewSharon Stoll, Kathleen Costello, Scott D Newsome, et al.
Multiple Sclerosis and Related Disorders|November 10, 2019
Validation of claims-based diagnoses of adult and pediatric neuromyelitis optica spectrum disorder and variations in diagnostic evaluation and treatment initiationSabrina Gmuca, Duriel I Hardy, Sona Narula, et al.
Frontiers in Neuroscience|October 2, 2023
Interim guidelines for the assessment and treatment of pain in children with multiple sclerosisCatherine Stratton, Areti Vassilopoulos, J Nicholas Brenton, et al.
Lancet (London, England)|May 28, 2026
Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trialsStephen L Hauser, Gavin Giovannoni, Xavier Montalban, et al.
Pageof 1